Increased levels of TWEAK in skeletal muscle favors the development of visceral obesity, accompanied with insulin resistance, and metabolic dysfunction, suggesting that TWEAK inhibition could be a potential approach to prevent weight gain and type 2 diabetes [134]. The gene discussed is TNFSF12; the disease is type 2 diabetes mellitus.